Pioneer in Robotic Joint Replacement Surgery Joins World #1 in Orthopedics at HSS Florida
News provided by
Share this article
Share this article
WEST PALM BEACH, Fla., Jan. 19, 2021 /PRNewswire/ Martin W. Roche, MD, who performed the world s first sensor and robotic assisted knee surgery, has joined HSS Florida in West Palm Beach. HSS is ranked #1 in the world for Orthopedics by Newsweek and is the world s leading academic medical center specialized in orthopedics, rheumatology, and related disciplines.
Martin W. Roche, MD, Director of Hip and Knee Arthroplasty at HSS Florida
Dr. Roche is a board-certified orthopedic surgeon and pioneer of complex knee reconstruction, including robotic and sensor-assisted partial and total knee joint replacements. He has performed thousands of minimally invasive reconstructive joint procedures, and works extensively with professional, amateur and recreational athletes, served as a Consultant Team Physician for the Miami Marlins, and is a mem
About Hospital for Special Surgery
HSS is the world’s leading academic medical center focused on musculoskeletal health. At its core is Hospital for Special Surgery, nationally ranked No. 1 in orthopedics (for the 11th consecutive year), No. 4 in rheumatology by U.S. News & World Report (2020-2021), and named a leader in pediatric orthopedics by U.S. News & World Report “Best Children’s Hospitals” list (2020-2021). HSS is ranked world #1 in orthopedics by Newsweek (2020-2021). Founded in 1863, the Hospital has the lowest complication and readmission rates in the nation for orthopedics, and among the lowest infection rates. HSS was the first in New York State to receive Magnet Recognition for Excellence in Nursing Service from the American Nurses Credentialing Center four consecutive times. The global standard total knee replacement was developed at HSS in 1969. An affiliate of Weill Cornell Medical College, HSS has a main campus in New York City and facilities in New Jersey,
New COVID-19 variant discovered in California as U S onenewspage.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onenewspage.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: Provides all-inclusive access to the critical pillars of human gene therapy: research, methods, and clinical applications. view more
Credit: Mary Ann Liebert, Inc., publishers
New Rochelle, NY, January 15, 2021 The biodistribution of adeno-associated virus (AAV) gene transfer vectors can be measured in nonhuman primates using a new method. The method quantifies whole-body and organ-specific AAV capsids from 1 to 72 hours after administration. Study design and results are presented in the peer-reviewed journal
Human Gene Therapy. Click here to read the full-text article free on the
Human Gene Therapy website through February 15, 2021.
AAV capsids were labeled with I-124 and delivered using two routes of administration: intravenous and directly into the cerebrospinal fluid (CSF). Biodistribution was measured by quantitative positron emission tomography (PET) at 1, 24, 48, and 72 hours after AAV administration. Two AAV vectors - AAVrsh.10 and AAV9 - we
Arthritis Drugs Impressive for Severe COVID but Not Magic Cure medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.